Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446511 · ClinicalTrials.gov registry record · Phase 3
Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension
A Phase 3 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT00446511 is a Phase 3 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 250 participants.
The verdict
NCT00446511, a Phase 3 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this extension study is to compare the long-term safety of valsartan versus enalapril, and the effectiveness of the combination of valsartan and enalapril versus enalapril alone in children with hypertension.
Interventions
- DRUG Valsartan
- DRUG Enalapril
- DRUG placebo matched to enalapril
- DRUG placebo matched to valsartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00446511
The ClinicalTrials.gov registry entry for NCT00446511 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Valsartan is the first listed.
NCT00446511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00446511 about?
NCT00446511 is a clinical study titled "Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension". The purpose of this extension study is to compare the long-term safety of valsartan versus enalapril, and the effectiveness of the combination of valsartan and enalapril versus enalapril alone in children with hypertension.
What is the current status of trial NCT00446511?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2007-06. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00446511?
The interventions under investigation include: Valsartan (DRUG), Enalapril (DRUG), placebo matched to enalapril (DRUG), placebo matched to valsartan (DRUG).
Who is sponsoring clinical trial NCT00446511?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.